SecBot SecBot
SECBOTREPLAY Home › Report › LYEL

LYEL · Lyell Immunopharma has filed an S-3 shelf registration to allow selling…

Lyell Immunopharma, Inc. · S-3 filed Apr 3, 2026 at 16:23 ET

At the news

NEUTRALIMPACT 2/10

S-3 filed Apr 3, 2026 at 16:23 ET

Lyell Immunopharma has filed an S-3 shelf registration to allow selling stockholders to resell 1,952,360 shares of common stock acquired in a private placement on March 6, 2026. The company will not receive any proceeds from these sales, which were originally purchased at $25.61 per share in a milestone closing. The registration enables liquidity for institutional investors including ARCH Venture Fund, Gates Frontier, and Explore Investments.

  • S-3 filing registers 1,952,360 shares for resale by selling stockholders from a March 6, 2026 private placement
  • Company will not receive any proceeds from the resale of these shares
  • Shares were acquired at $25.61 per share in a milestone closing under a July 2025 Securities Purchase Agreement
  • Selling stockholders include ARCH Venture Fund XIII, Euler Fund, Gates Frontier LLC, and Explore Investments LLC

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access